491 related articles for article (PubMed ID: 15791658)
1. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
2. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
[TBL] [Abstract][Full Text] [Related]
3. Cell-free fetal DNA levels in pregnancies conceived by IVF.
Pan PD; Peter I; Lambert-Messerlian GM; Canick JA; Bianchi DW; Johnson KL
Hum Reprod; 2005 Nov; 20(11):3152-6. PubMed ID: 16006472
[TBL] [Abstract][Full Text] [Related]
4. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
5. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
6. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome.
Muller F; Dreux S; Lemeur A; Sault C; Desgrès J; Bernard MA; Giorgetti C; Lemay C; Mirallié S; Beauchet A;
Prenat Diagn; 2003 Dec; 23(13):1073-6. PubMed ID: 14691995
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
8. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
[TBL] [Abstract][Full Text] [Related]
10. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
[TBL] [Abstract][Full Text] [Related]
11. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
12. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum screening for fetal Down syndrome in IVF pregnancies.
Ribbert LS; Kornman LH; De Wolf BT; Simons AH; Jansen CA; Beekhuis JR; Mantingh A
Prenat Diagn; 1996 Jan; 16(1):35-8. PubMed ID: 8821850
[TBL] [Abstract][Full Text] [Related]
14. Second-trimester maternal serum analyte levels associated with fetal trisomy 13.
Saller DN; Canick JA; Blitzer MG; Palomaki GE; Schwartz S; Blakemore KJ; Haddow JE
Prenat Diagn; 1999 Sep; 19(9):813-6. PubMed ID: 10521837
[TBL] [Abstract][Full Text] [Related]
15. First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study.
Lambert-Messerlian G; Dugoff L; Vidaver J; Canick JA; Malone FD; Ball RH; Comstock CH; Nyberg DA; Saade G; Eddleman K; Klugman S; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME
Prenat Diagn; 2006 Aug; 26(8):672-8. PubMed ID: 16764012
[TBL] [Abstract][Full Text] [Related]
16. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
Benn PA; Ying J; Beazoglou T; Egan JF
Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
[TBL] [Abstract][Full Text] [Related]
17. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
18. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM
Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244
[TBL] [Abstract][Full Text] [Related]
19. Second trimester serum markers.
Canick JA; MacRae AR
Semin Perinatol; 2005 Aug; 29(4):203-8. PubMed ID: 16104669
[TBL] [Abstract][Full Text] [Related]
20. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]